Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Liver Cirrhosis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Liver Cirrhosis Therapeuticsmarket, defines the market attractiveness level of Liver Cirrhosis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Liver Cirrhosis Therapeutics industry, describes the types of Liver Cirrhosis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Liver Cirrhosis Therapeutics market and the development prospects and opportunities of Liver Cirrhosis Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Liver Cirrhosis Therapeutics market in Chapter 13.
By Player:
Gilead Sciences
Roche
Conatus Pharmaceuticals
Merck
Gwo Xi Stem Cell Applied Technology
Bristol-Myers Squibb
GlaxoSmithKline
Johnson & Johnson
By Type:
Alcoholic cirrhosis
Postnecrotic cirrhosis
Biliary cirrhosis
Cardiac cirrhosis
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Liver Cirrhosis Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Liver Cirrhosis Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Liver Cirrhosis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Liver Cirrhosis Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Liver Cirrhosis Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Liver Cirrhosis Therapeutics Consumption (2017-2022)
-
7.2 United States Liver Cirrhosis Therapeutics Consumption (2017-2022)
-
7.3 Europe Liver Cirrhosis Therapeutics Consumption (2017-2022)
-
7.4 China Liver Cirrhosis Therapeutics Consumption (2017-2022)
-
7.5 Japan Liver Cirrhosis Therapeutics Consumption (2017-2022)
-
7.6 India Liver Cirrhosis Therapeutics Consumption (2017-2022)
-
7.7 South Korea Liver Cirrhosis Therapeutics Consumption (2017-2022)
8 Region and Country-wise Liver Cirrhosis Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Liver Cirrhosis Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Liver Cirrhosis Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Liver Cirrhosis Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Liver Cirrhosis Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Liver Cirrhosis Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Liver Cirrhosis Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Liver Cirrhosis Therapeutics Consumption Forecast (2022-2028)
9 Global Liver Cirrhosis Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Liver Cirrhosis Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Alcoholic cirrhosis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Postnecrotic cirrhosis Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Biliary cirrhosis Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cardiac cirrhosis Consumption and Growth Rate (2017-2022)
-
9.2 Global Liver Cirrhosis Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Liver Cirrhosis Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Liver Cirrhosis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Alcoholic cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Postnecrotic cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Biliary cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Cardiac cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Liver Cirrhosis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Liver Cirrhosis Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Liver Cirrhosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Liver Cirrhosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Liver Cirrhosis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Liver Cirrhosis Therapeutics Market Competitive Analysis
-
14.1 Gilead Sciences
-
14.1.1 Gilead Sciences Company Details
-
14.1.2 Gilead Sciences Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gilead Sciences Liver Cirrhosis Therapeutics Product and Service
-
14.2 Roche
-
14.2.1 Roche Company Details
-
14.2.2 Roche Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Liver Cirrhosis Therapeutics Product and Service
-
14.3 Conatus Pharmaceuticals
-
14.3.1 Conatus Pharmaceuticals Company Details
-
14.3.2 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Liver Cirrhosis Therapeutics Product and Service
-
14.5 Gwo Xi Stem Cell Applied Technology
-
14.5.1 Gwo Xi Stem Cell Applied Technology Company Details
-
14.5.2 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product and Service
-
14.6 Bristol-Myers Squibb
-
14.6.1 Bristol-Myers Squibb Company Details
-
14.6.2 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Liver Cirrhosis Therapeutics Product and Service
-
14.8 Johnson & Johnson
-
14.8.1 Johnson & Johnson Company Details
-
14.8.2 Johnson & Johnson Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Johnson & Johnson Liver Cirrhosis Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Liver Cirrhosis Therapeutics
-
Figure Liver Cirrhosis Therapeutics Picture
-
Table Global Liver Cirrhosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liver Cirrhosis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liver Cirrhosis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Liver Cirrhosis Therapeutics Consumption by Country (2017-2022)
-
Figure United States Liver Cirrhosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Liver Cirrhosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Liver Cirrhosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Liver Cirrhosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Liver Cirrhosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Liver Cirrhosis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cirrhosis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Liver Cirrhosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Liver Cirrhosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Liver Cirrhosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Liver Cirrhosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Liver Cirrhosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Liver Cirrhosis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alcoholic cirrhosis Consumption and Growth Rate (2017-2022)
-
Figure Global Postnecrotic cirrhosis Consumption and Growth Rate (2017-2022)
-
Figure Global Biliary cirrhosis Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiac cirrhosis Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Alcoholic cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Postnecrotic cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biliary cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiac cirrhosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Liver Cirrhosis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Liver Cirrhosis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Liver Cirrhosis Therapeutics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Liver Cirrhosis Therapeutics Product and Service
-
Table Conatus Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Liver Cirrhosis Therapeutics Product and Service
-
Table Gwo Xi Stem Cell Applied Technology (Foundation Year, Company Profile and etc.)
-
Table Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Liver Cirrhosis Therapeutics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Liver Cirrhosis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Liver Cirrhosis Therapeutics Product and Service
-
